Who are the key players in oligonucleotide synthesis market?

Some key players operating in the oligonucleotide synthesis market include Thermo Fisher Scientific, Inc; Merck KGaA; Danaher Corporation; Dharmacon Inc.; Agilent Technologies, Inc.; Bio-Synthesis; Kaneka Eurogentec S.A.; LGC Biosearch Technologies; Biolegio; Twist Bioscience

What are the factors driving the oligonucleotide synthesis market?

Key factors that are driving the oligonucleotide synthesis market growth include the declining cost of sequencing, technological advancements in gene editing technologies, and rising investments in genetic research.

How big is the oligonucleotide synthesis market?

The global oligonucleotide synthesis market size was estimated at USD 3.64 billion in 2025 and is expected to reach USD 4.10 billion in 2026.

What is the oligonucleotide synthesis market growth?

The global oligonucleotide synthesis market is expected to grow at a compound annual growth rate of 14.95% from 2026 to 2033 to reach USD 10.86 billion by 2033.

Which segment accounted for the largest oligonucleotide synthesis market share?

Services dominated the oligonucleotide synthesis market with a share of 38.03 % in 2025. This is attributable to the increasing demand for oligonucleotides in precision medicine.